Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice
- PMID: 8554976
- PMCID: PMC2074291
- DOI: 10.1038/bjc.1996.3
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice
Abstract
A role for antigen stimulation in lymphoid neoplasia has been postulated and is supported by indirect evidence that suggests that the interaction of antigen with both T cells and B cells may constitute an epigenetic event that can contribute to tumour induction or tumour progression. Using myc-bearing transgenic mice that develop mainly clonal T-cell lymphomas we have investigated the possibility that endogenous antigen-mediated clonal deletion might be overridden in tumorigenesis. CD2-myc transgenic mice were backcrossed on to a CBA/Ca background to ensure Mtv-mediated deletion of V beta 11-expressing T cells in the resultant offspring. Lymphomas arising from these mice were subsequently screened for V beta 11 expression. There was a clear correlation between the age at which mice developed neoplasia and the tumour phenotype. Mice with CD4- CD8+ tumours succumbed to thymic lymphoma at a significantly younger age than mice developing CD4+ CD8+ tumours. A small number of tumours consisted of the 'forbidden' V beta 11 phenotype, showing that cells vulnerable to transformation could escape negative selection. The majority of the V beta 11-positive tumours were CD4- CD8+ and were only observed in mice showing clinical evidence of tumour development at a relatively young age. The phenotype of these cells and the age at which tumours arose suggests that T cells escaping tolerance may be susceptible to transformation.
Similar articles
-
CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.Immunology. 1997 Dec;92(4):437-46. doi: 10.1046/j.1365-2567.1997.00382.x. Immunology. 1997. PMID: 9497484 Free PMC article.
-
Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.Int J Cancer. 1993 Apr 1;53(6):1023-30. doi: 10.1002/ijc.2910530628. Int J Cancer. 1993. PMID: 8473043
-
Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.J Immunol. 2001 Jul 15;167(2):715-23. doi: 10.4049/jimmunol.167.2.715. J Immunol. 2001. PMID: 11441075
-
Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.Thymus. 1994;23(1):1-13. Thymus. 1994. PMID: 7863543 Review.
-
CD4/CD8 lineage commitment in T cell receptor transgenic mice: evidence for precommitment of CD4+ CD8+ thymocytes.Semin Immunol. 1994 Aug;6(4):249-56. doi: 10.1006/smim.1994.1032. Semin Immunol. 1994. PMID: 8000034 Review.
Cited by
-
Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2118529119. doi: 10.1073/pnas.2118529119. Epub 2022 Jun 29. Proc Natl Acad Sci U S A. 2022. PMID: 35767640 Free PMC article.
-
Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?Br J Cancer. 1997;76(6):739-46. doi: 10.1038/bjc.1997.455. Br J Cancer. 1997. PMID: 9310239 Free PMC article.
-
Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.Mol Cell Biol. 2006 Mar;26(6):2080-92. doi: 10.1128/MCB.26.6.2080-2092.2006. Mol Cell Biol. 2006. PMID: 16507988 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials